VIVA Biotech Holdings
HKEX:1873
VIVA Biotech Holdings
Operating Income
VIVA Biotech Holdings
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
V
|
VIVA Biotech Holdings
HKEX:1873
|
Operating Income
¥211.1m
|
CAGR 3-Years
33%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Operating Income
¥11.5B
|
CAGR 3-Years
52%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Operating Income
¥1.8B
|
CAGR 3-Years
18%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Operating Income
¥4.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Operating Income
¥1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
34%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Operating Income
¥190.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is VIVA Biotech Holdings's Operating Income?
Operating Income
211.1m
CNY
Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Operating Income amounts to 211.1m CNY.
What is VIVA Biotech Holdings's Operating Income growth rate?
Operating Income CAGR 5Y
31%
Over the last year, the Operating Income growth was -29%. The average annual Operating Income growth rates for VIVA Biotech Holdings have been 33% over the past three years , 31% over the past five years .